TAVOLARI, SIMONA
TAVOLARI, SIMONA
CENTRO INTERDIPARTIMENTALE ALMA MATER INSTITUTE ON HEALTHY PLANET
Assegnisti
Tavolari S.; Simona Tavolari; S. TAVOLARI
219 MiR-21 expression correlates with prognosis in extrahepatic radically resected cholangiocarcinomas treated with gemcitabine-based adjuvant chemotherapy
2015 Garajová, I.; Brandi, G.; Biasco, G.; Deserti, M.; Tavolari, S.; Palloni, A.; Verlicchi, L.; Le Large, T.; Giovannetti, E.
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
2024 Brandi G.; Relli V.; Deserti M.; Palloni A.; Indio V.; Astolfi A.; Serravalle S.; Mattiaccio A.; Vasuri F.; Malvi D.; Deiana C.; Pantaleo M.A.; Cescon M.; Rizzo A.; Katoh M.; Tavolari S.
Adjuvant treatment in biliary tract cancer
2019 Andrea Palloni, Giorgio Frega, Stefania De Lorenzo, Alessandro Rizzo, Francesca Abbati, Marzia Deserti, Simona Tavolari, Giovanni Brandi
Angiogenesis modulation in human umbilical endothelial vein (HUVE) cells by selected polychlorobiphenyls congeners is mediated by estrogen receptor alpha (ERα) binding.
2006 Tavolari S.; Bucci L.; Tomasi V.; Guarnieri T.
Annellated pyrrole compounds for cancer management
2009 S. Laufer; T. Guarnieri; S. Tavolari; V. Tomasi; E. Palazzini; M. Barbanti
Annellated pyrrole compounds for cancer management
2008 S. Laufer; T. Guarnieri; S. Tavolari; V. Tomasi; E. Palazzini; M. Barbanti
Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: A systematic review and meta-analysis
2020 Rizzo A.; Frega G.; Ricci A.D.; Palloni A.; Abbati F.; de Lorenzo S.; Deserti M.; Tavolari S.; Brandi G.
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment
2012 M Macchini; G Brandi; S Tavolari; T Guarnieri; M Di Marco; P Paterini; F De Rosa; S Di Girolamo; S Vecchiarelli; A Papi; G Biasco
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study.
2014 Brandi G;Tavolari S;Guarnieri T;Di Marco M;Paterini P;Macchini M;Di Girolamo S;Papi A;De Rosa F;Biasco G
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations
2012 G. Brandi; S. tavolari; f. de rosa;s. di girolamo;v. agostini; m.a. barbera; g. frega; g. biasco
Antitumoral Efficacy of Two Turmeric Extracts According to Different Extraction Methods in Hepatocellular Carcinoma Cell Lines
2018 Deserti, Marzia; Tavolari, Simona; Naldi, Marina; Frega, Giorgio; Brandi, Giovanni
Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue
2023 Brandi G.; Deiana C.; Galvani L.; Palloni A.; Ricci A.D.; Rizzo A.; Tavolari S.
Asbestos and Intrahepatic Cholangiocarcinoma
2020 Brandi G.; Tavolari S.
Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study
2023 Vasuri, Francesco; Deserti, Marzia; Corradini, Angelo G; Tavolari, Simona; Relli, Valeria; Palloni, Andrea; Frega, Giorgio; Curti, Stefania; Mattioli, Stefano; Cescon, Matteo; D'Errico, Antonia; Brandi, Giovanni
Carcinogenesis of Cholangiocarcinoma
2015 Tavolari, Simona; Venturi, Michela; Brandi, Giovanni
Cholangiocarcinoma: Epidemiology and risk factors
2019 Khan S.A.; Tavolari S.; Brandi G.
Circulating tumor DNA in biliary tract cancer: Current evidence and future perspectives
2020 Rizzo A.; Ricci A.D.; Tavolari S.; Brandi G.
Current and novel therapeutic opportunities for systemic therapy in biliary cancer
2020 Marin J.J.G.; Prete M.G.; Lamarca A.; Tavolari S.; Landa-Magdalena A.; Brandi G.; Segatto O.; Vogel A.; Macias R.I.R.; Rodrigues P.M.; Casta A.L.; Mertens J.; Rodrigues C.M.P.; Fernandez-Barrena M.G.; Da Silva Ruivo A.; Marzioni M.; Mentrasti G.; Acedo P.; Munoz-Garrido P.; Cardinale V.; Banales J.M.; Valle J.W.; Bridgewater J.; Braconi C.
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC)
2009 Brandi, Giovanni; Paterini, Paola; Tavolari, Simona; dal Pozzo, G.; Nobili, Elisabetta; DI CICILIA, Roberto; DI MARCO, Mariacristina; Pantaleo, MARIA ABBONDANZA; DE ROSA, Francesco; Biasco, Guido
Evolution of the experimental models of cholangiocarcinoma
2020 Massa A.; Varamo C.; Vita F.; Tavolari S.; Peraldo-Neia C.; Brandi G.; Rizzo A.; Cavalloni G.; Aglietta M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 219 MiR-21 expression correlates with prognosis in extrahepatic radically resected cholangiocarcinomas treated with gemcitabine-based adjuvant chemotherapy | Garajová, I.; Brandi, G.; Biasco, G.; Deserti, M.; Tavolari, S.; Palloni, A.; Verlicchi, L.; Le L...arge, T.; Giovannetti, E. | 2015-01-01 | EUROPEAN JOURNAL OF CANCER | - | 4.03 Poster | - |
| Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies | Brandi G.; Relli V.; Deserti M.; Palloni A.; Indio V.; Astolfi A.; Serravalle S.; Mattiaccio A.; ...Vasuri F.; Malvi D.; Deiana C.; Pantaleo M.A.; Cescon M.; Rizzo A.; Katoh M.; Tavolari S. | 2024-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | Brandi_2024.pdf; 41598_2024_52991_MOESM8_ESM.zip |
| Adjuvant treatment in biliary tract cancer |
Andrea Palloni, Giorgio Frega, Stefania De Lorenzo, Alessandro Rizzo, Francesca Abbati, Marzia D...eserti, Simona Tavolari, Giovanni Brandi |
2019-01-01 | TRANSLATIONAL CANCER RESEARCH | - | 1.01 Articolo in rivista | Adjuvant treatment in biliary tract cancer.pdf |
| Angiogenesis modulation in human umbilical endothelial vein (HUVE) cells by selected polychlorobiphenyls congeners is mediated by estrogen receptor alpha (ERα) binding. | Tavolari S.; Bucci L.; Tomasi V.; Guarnieri T. | 2006-01-01 | ACTA PHYSIOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Annellated pyrrole compounds for cancer management | S. Laufer; T. Guarnieri; S. Tavolari; V. Tomasi; E. Palazzini; M. Barbanti | 2009-01-01 | - | - | 6.01 Brevetto | - |
| Annellated pyrrole compounds for cancer management | S. Laufer; T. Guarnieri; S. Tavolari; V. Tomasi; E. Palazzini; M. Barbanti | 2008-01-01 | - | - | 6.01 Brevetto | - |
| Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: A systematic review and meta-analysis | Rizzo A.; Frega G.; Ricci A.D.; Palloni A.; Abbati F.; de Lorenzo S.; Deserti M.; Tavolari S.; Br...andi G. | 2020-01-01 | IN VIVO | - | 1.01 Articolo in rivista | - |
| Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment | M Macchini; G Brandi; S Tavolari; T Guarnieri; M Di Marco; P Paterini; F De Rosa; S Di Girolamo; ...S Vecchiarelli; A Papi; G Biasco | 2012-01-01 | PANCREATOLOGY | Academic Press (Elsevier) | 4.02 Riassunto (Abstract) | - |
| Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. | Brandi G;Tavolari S;Guarnieri T;Di Marco M;Paterini P;Macchini M;Di Girolamo S;Papi A;De Rosa F;B...iasco G | 2014-01-01 | PANCREAS | - | 1.01 Articolo in rivista | - |
| Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations | G. Brandi; S. tavolari; f. de rosa;s. di girolamo;v. agostini; m.a. barbera; g. frega; g. biasco | 2012-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | Antitumoral.pdf |
| Antitumoral Efficacy of Two Turmeric Extracts According to Different Extraction Methods in Hepatocellular Carcinoma Cell Lines | Deserti, Marzia; Tavolari, Simona; Naldi, Marina; Frega, Giorgio; Brandi, Giovanni | 2018-01-01 | MEDICINAL & AROMATIC PLANTS | - | 1.01 Articolo in rivista | Antitumoral Efficacy of Two Turmeric Extracts According to Different.pdf |
| Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue | Brandi G.; Deiana C.; Galvani L.; Palloni A.; Ricci A.D.; Rizzo A.; Tavolari S. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma.pdf |
| Asbestos and Intrahepatic Cholangiocarcinoma | Brandi G.; Tavolari S. | 2020-01-01 | CELLS | - | 1.01 Articolo in rivista | Asbestos and Intrahepatic Cholangiocarcinoma.pdf |
| Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study | Vasuri, Francesco; Deserti, Marzia; Corradini, Angelo G; Tavolari, Simona; Relli, Valeria; Pallon...i, Andrea; Frega, Giorgio; Curti, Stefania; Mattioli, Stefano; Cescon, Matteo; D'Errico, Antonia; Brandi, Giovanni | 2023-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | 70-Vasuri et al_Sci Rep 2023.pdf; 41598_2023_27791_MOESM1_ESM.pdf |
| Carcinogenesis of Cholangiocarcinoma | Tavolari, Simona; Venturi, Michela; Brandi, Giovanni | 2015-01-01 | - | Nova Science Publisher, Inc. | 2.01 Capitolo / saggio in libro | - |
| Cholangiocarcinoma: Epidemiology and risk factors | Khan S.A.; Tavolari S.; Brandi G. | 2019-01-01 | LIVER INTERNATIONAL | - | 1.01 Articolo in rivista | Khan_2019.pdf |
| Circulating tumor DNA in biliary tract cancer: Current evidence and future perspectives | Rizzo A.; Ricci A.D.; Tavolari S.; Brandi G. | 2020-01-01 | CANCER GENOMICS & PROTEOMICS. | - | 1.01 Articolo in rivista | - |
| Current and novel therapeutic opportunities for systemic therapy in biliary cancer | Marin J.J.G.; Prete M.G.; Lamarca A.; Tavolari S.; Landa-Magdalena A.; Brandi G.; Segatto O.; Vog...el A.; Macias R.I.R.; Rodrigues P.M.; Casta A.L.; Mertens J.; Rodrigues C.M.P.; Fernandez-Barrena M.G.; Da Silva Ruivo A.; Marzioni M.; Mentrasti G.; Acedo P.; Munoz-Garrido P.; Cardinale V.; Banales J.M.; Valle J.W.; Bridgewater J.; Braconi C. | 2020-01-01 | BRITISH JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC) | Brandi, Giovanni; Paterini, Paola; Tavolari, Simona; dal Pozzo, G.; Nobili, Elisabetta; DI CICILI...A, Roberto; DI MARCO, Mariacristina; Pantaleo, MARIA ABBONDANZA; DE ROSA, Francesco; Biasco, Guido | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Evolution of the experimental models of cholangiocarcinoma | Massa A.; Varamo C.; Vita F.; Tavolari S.; Peraldo-Neia C.; Brandi G.; Rizzo A.; Cavalloni G.; Ag...lietta M. | 2020-01-01 | CANCERS | - | 1.01 Articolo in rivista | Evolution of the Experimental Models.pdf |